MInT-studie M29045
| Titel | Intergroup Trial of First Line Treatment for Patients with Diffuse Large B-cell Non-Hodgkin´s Lymphoma with a CHOP-Like Chemotherapy Regimen with or without the anti-CD20 Antibody Rituximab (IDEC-C2B8) |
|
| Akronym | MInT-studie M29045 |
|
| Typ av studie | Randomiserad fas-III multicenterstudie |
|
| Sponsor | The Mabthera International Trial (MInT) Study Group |
|
| Inklusionskriterier | Ålder 18 - 60 år |
|
| Studiedesign |  |
CHOP CHOP + Rituximab |
| Endpoint(s) | Time to treatment failure (TTTF) | |
| Rekryteringsperiod | 2000-08-01 – 2003-10-20 | |
| Antal inkluderade patienter | 820 |
|
| Publikationer |
|
|
 Tillbaka till Kliniska prövningar |
||
Uppdaterad: 2008 01 03